Lamivudine/dolutegravir is effective as first-line therapy for HIV infection, with low rates of treatment failure.

Patients who achieved HIV virologic suppression tended to be older and were more likely to report continued engagement in HIV care than those with persistent viremia.

Research published in The Lancet HIV earlier this year, experts estimated that, if purchased at scale, the cost of generic lenacapavir could range from USD 35 to USD 46 per person-year. Falling to USD ...

Indian drugmakers Dr Reddy's Laboratories and Hetero Labs said on Wednesday that they will sell generic versions of a new and ...

(CNN) — The United States has suspended some funding for its flagship AIDS relief program, according to international organizations and members of Congress who warn the cuts are already hurting ...

In April 2025, we published a story with the headline: "Haunted by hopelessness: 12 Zambians share their stories as HIV drugs run out." It looked at the impact of President Trump's cuts to foreign aid ...

The plan to target pregnant and breastfeeding mothers will be administered through the President’s Emergency Plan for AIDS Relief. Critics said it appeared to sidestep LGBTQ+ people. The Trump ...

Gilead Sciences, the largest maker of HIV medicines, is seeking to boost prices significantly for several treatments that are widely distributed by state AIDS Drug Assistance Programs. And the move is ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...

A multi-institutional team led by Weill Cornell Medicine has received a five-year, $14.9 million grant from the National Institute of Allergy and Infectious Diseases, part of the National Institutes ...